HomeRAPH • OTCMKTS
add
Raphael Pharmaceutical Inc
Previous close
$0.22
Year range
$0.15 - $1.65
Market cap
4.32M USD
Avg Volume
55.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 425.00K | -22.30% |
Net income | -429.00K | 22.00% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 50.00K | -82.58% |
Total assets | 93.00K | -73.65% |
Total liabilities | 827.00K | 81.36% |
Total equity | -734.00K | — |
Shares outstanding | 19.63M | — |
Price to book | -5.50 | — |
Return on assets | -1,770.83% | — |
Return on capital | 152.44% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -429.00K | 22.00% |
Cash from operations | -209.00K | -21.51% |
Cash from investing | — | — |
Cash from financing | 240.00K | 4.35% |
Net change in cash | 31.00K | -45.61% |
Free cash flow | -48.12K | 37.30% |
About
Founded
2007
Headquarters
Website
